Fragile X syndrome and the amygdala
- PMID: 21555214
- DOI: 10.1016/j.conb.2011.04.005
Fragile X syndrome and the amygdala
Abstract
Fragile X syndrome (FXS) is the most commonly inherited form of mental impairment and autism. Current understanding of the molecular and cellular mechanisms underlying FXS symptoms is derived mainly from studies on the hippocampus and cortex. However, FXS is also associated with strong emotional symptoms, which are likely to involve changes in the amygdala. Unfortunately, the synaptic basis of amygdalar dysfunction in FXS remains largely unexplored. Here we describe recent findings from mouse models of FXS that have identified synaptic defects in the basolateral amygdala that are in many respects distinct from those reported earlier in the hippocampus. Long-term potentiation and surface expression of AMPA-receptors are impaired. Further, presynaptic defects are seen at both excitatory and inhibitory synapses. Remarkably, some of these synaptic defects in the amygdala are also amenable to pharmacological rescue. These results also underscore the need to modify the current hippocampus-centric framework to better explain FXS-related synaptic dysfunction in the amygdala.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Developmental changes in expression of inhibitory neuronal proteins in the Fragile X Syndrome mouse basolateral amygdala.Brain Res. 2013 Nov 6;1537:69-78. doi: 10.1016/j.brainres.2013.08.052. Epub 2013 Sep 2. Brain Res. 2013. PMID: 24008143
-
Fragile X syndrome: the GABAergic system and circuit dysfunction.Dev Neurosci. 2011;33(5):349-64. doi: 10.1159/000329420. Epub 2011 Sep 21. Dev Neurosci. 2011. PMID: 21934270 Free PMC article. Review.
-
Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus.J Neurosci Res. 2011 Feb;89(2):176-82. doi: 10.1002/jnr.22546. Epub 2010 Dec 8. J Neurosci Res. 2011. PMID: 21162125
-
Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome.Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11591-6. doi: 10.1073/pnas.1002262107. Epub 2010 Jun 7. Proc Natl Acad Sci U S A. 2010. PMID: 20534533 Free PMC article.
-
Differential translation and fragile X syndrome.Genes Brain Behav. 2005 Aug;4(6):360-84. doi: 10.1111/j.1601-183X.2005.00134.x. Genes Brain Behav. 2005. PMID: 16098135 Review.
Cited by
-
Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats.Neuropsychopharmacology. 2023 May;48(6):897-907. doi: 10.1038/s41386-022-01454-7. Epub 2022 Sep 16. Neuropsychopharmacology. 2023. PMID: 36114286 Free PMC article.
-
Control of Behavioral Arousal and Defense by a Glutamatergic Midbrain-Amygdala Pathway in Mice.Front Neurosci. 2022 Apr 18;16:850193. doi: 10.3389/fnins.2022.850193. eCollection 2022. Front Neurosci. 2022. PMID: 35527820 Free PMC article.
-
Rett Syndrome and Fragile X Syndrome: Different Etiology With Common Molecular Dysfunctions.Front Cell Neurosci. 2021 Nov 19;15:764761. doi: 10.3389/fncel.2021.764761. eCollection 2021. Front Cell Neurosci. 2021. PMID: 34867203 Free PMC article. Review.
-
Experiential contributions to social dominance in a rat model of fragile-X syndrome.Proc Biol Sci. 2018 Jun 13;285(1880):20180294. doi: 10.1098/rspb.2018.0294. Proc Biol Sci. 2018. PMID: 29899064 Free PMC article.
-
The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality?Front Synaptic Neurosci. 2017 Nov 6;9:15. doi: 10.3389/fnsyn.2017.00015. eCollection 2017. Front Synaptic Neurosci. 2017. PMID: 29163124 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical